MORGAN STANLEY PLC/CALL/STRYKER CORP./520/0.1/20.12.24 Stock

Warrant

DE000ME9BQP2

Real-time Bid/Ask 10:14:53 2024-05-13 am EDT
0.121 EUR / 0.158 EUR +13.82% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./520/0.1/20.12.24
Current month-11.51%
1 month-28.49%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-13 0.123 0.00% 0
24-05-10 0.123 0.00% 0
24-05-09 0.123 0.00% 0
24-05-08 0.123 -0.81% 0
24-05-07 0.124 +0.81% 0

Delayed Quote Börse Stuttgart

Last update May 13, 2024 at 08:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQP
ISINDE000ME9BQP2
Date issued 2024-02-27
Strike 520 $
Maturity 2024-12-20 (221 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.31
Lowest since issue 0.104
Spread 0.044
Spread %27.16%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW